Drug Information

Drug General Information
Drug ID
D0J3RP
Former ID
DNCL002869
Drug Name
ISIS-GCCRrx
Indication Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] Phase 2 [524485]
Company
Isis Pharmaceuticals
Target and Pathway
Target(s) Guanylyl cyclase C Target Info Modulator [543471]
References
Ref 524485ClinicalTrials.gov (NCT01968265) Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes. U.S. National Institutes of Health.
Ref 543471(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1750).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.